Head and Neck Cancer Trial, Recruiting NCT07296250 Sponsor: Chang Gung Memorial Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07296250
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 90 years of age
  • People who have been diagnosed with a type of head and neck cancer called squamous cell carcinoma, confirmed through laboratory testing of tissue samples
  • People who have completed surgery for their cancer, been identified as having high-risk factors, and are receiving a combination of chemotherapy and radiation therapy at the same time
  • People who are willing to attend follow-up visits at the hospital after their treatment is finished

Who may not be able to join:

  • People who have a psychiatric (mental health) disorder
  • People whose treating doctor considers them unsuitable for participation in the trial
  • People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: ChunTa Liao, PhD, Division of Otolaryngology, Chang Gung Memorial Hospital

Phone: 0975360141

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
31 July 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Circulating tumor cells (CTCs) testing; Circulating tumor cells (CTCs) testing; Circulating tumor cells (CTCs) testing; Circulating tumor cells (CTCs) testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov